The skincare industry has embraced GHK-Cu with considerable commercial enthusiasm, incorporating it into serums, creams, masks, and microneedling treatments at concentrations ranging from 0.01% to 1%
Further supporting this concern, a systematic review of observational and interventional studies in patients with heart failure with reduced ejection fraction (HFrEF) receiving RAASi reported moderate-to-severe hyperkalemia rates as high as 38.2% in observational cohorts and 19.0% in clinical trials
doi:10.3390/nu14040852 Kahathuduwa, C.N., Wakefield, S., West, B.D
Studies suggest that Semaglutide may help lower cardiovascular risk factors, such as high blood pressure and cholesterol levels, thereby reducing the likelihood of heart attack and stroke
Humana administers commercial employer plans through fully-insured and self-funded arrangements
Your healthcare provider can assess your health status, medical history, and medications and provide personalized recommendations and dosages for optimal results
